LuciRit

Description

COMPOSITION:

Each LuciRit capsule contains Ritlecitinib tosylate 80.13 mg equivalent to Ritlecitinib……………….. 50 mg

INDICATION:

LuciRit is a kinase inhibitor indicated for the treatment of severe alopecia areata in adults and adolescents 12 years and older.

DOSAGE AND USE:

The recommended dosage of LuciRit is 50 mg orally once daily with or without food. If treatment interruption is indicated, a temporary treatment interruption for less than 6 weeks is not expected to result in significant loss of regrown scalp hair.

Capsule should be swallowed whole & not chewed or crushed

STORAGE:

in a dry place and store at 20°C to 25°C.

MANUFACTURED AND MARKETED BY:

LUCIUS PHARMACEUTICALS(LAO) CO., LTD

No.26, Thongmang village, Xaythany district, Vientiane Capital, Laos

WARNING:

Keep medicine out of reach of Children. Do not administered LuciRit in Pregnancy and Lactation patient treatment.